Compare Best Buy Co Inc (BBY) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Best Buy Co Inc vs Bristol-Myers Squibb Co — how do they compare? Best Buy Co Inc trades at $85.34 (market cap $17.49B), while Bristol-Myers Squibb Co trades at $64.69 (market cap $130.12B). The key difference: Bristol-Myers Squibb Co is far larger — about 7.4× Best Buy Co Inc's market cap, and Best Buy Co Inc pays the higher dividend (4.63%). Which is the better fit depends on your goals.
| BBY | BMY | |
|---|---|---|
Market Cap | $17.49B | $130.12B |
Sector | Consumer Cyclical | Health |
52-Week High | $90.17 | $65.89 |
52-Week Low | $55.52 | $42.60 |
Enterprise Value | $19.87B | $164.11B |
Dividend Yield | 4.63% | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Best Buy Co Inc
With $51.8 billion in fiscal 2022 sales, Best Buy is the largest pure-play consumer electronics retailer in the U.S., with roughly 10.6% share of the aggregate market and north of 40% share of offline sales, per our calculations, CTA industry, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the COVID-19 pandemic, have seen the U.S. e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Read more on BBY →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
